Post-approval studies (Phase 4)UnknownNCT04863638
What this trial is testing
A Immuno-bridging and Immunization Schedules Study of COVID-19 Vaccine (Vero Cell), Inactivated
Who this might be right for
Covid19
China National Biotec Group Company Limited 4,400